Altea Therapeutics
Altea Therapeutics Announces Development and Commercialization Agreement with Amylin and Lilly for an Investigational Transdermal Exenatide
Published in Medical Device Business Week, April 15th, 2009
Altea Therapeutics announced that it has entered into an agreement with Eli Lilly and Company and Amylin Pharmaceuticals, Inc. to develop and commercialize a novel daily transdermal patch delivering sustained levels of exenatide utilizing the Altea Therapeutics proprietary PassPort® Transdermal Delivery System. Altea Therapeutics, supported by Lilly and Amylin, recently completed an initial Phase 1 clinical study of the exenatide transdermal patch in people with type 2 diabetes.
The exenatide transdermal patch is an investigational product designed to be applied once per day to provide sustained levels of exenatide for people with type 2 diabetes. The potential benefits...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Acusphere, Inc.
Acusphere, Inc. Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results - AeroScout, Inc.
AeroScout Announces World’s First Wi-Fi Asset Tracking Solution With Embedded Ultrasound Capabilities - Alcon, Inc.
Alcon and the Asthma and Allergy Foundation of America Team Up to Educate Patients - Ambulatory Surgery
Medical Web Technologies Enables Ambulatory Surgery Centers to Meet New CMS Regulatory Guidelines on Patient Rights - America Hears, Inc.
America Hears, Inc., Strengthens Management Team With New President and Expanded Board of Directors - Angiology
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
